New therapeutic approaches for metastatic thyroid carcinoma.
about
Thyroid computed tomography imaging: pictorial review of variable pathologies.Molecular Targeted Therapies of Aggressive Thyroid CancerSpinal metastasis in thyroid cancerIdentification of a recurrent STRN/ALK fusion in thyroid carcinomasGEMOX regimen in the treatment of metastatic differentiated refractory thyroid carcinoma.Thyroid cancer: current molecular perspectives.Spinal cord compression as initial presentation of metastatic occult follicular thyroid carcinomaB-Raf(V600E) and thrombospondin-1 promote thyroid cancer progressionMulti-targeted approach in the treatment of thyroid cancer.S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.Management of differentiated thyroid carcinoma with bone metastasis: a case report and review of the Chinese literaturePhase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation.The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.Genome-wide expression analysis suggests a crucial role of dysregulation of matrix metalloproteinases pathway in undifferentiated thyroid carcinomaNew therapies for dedifferentiated papillary thyroid cancerA detailed clinicopathologic study of ALK-translocated papillary thyroid carcinoma.Standard and emerging therapies for metastatic differentiated thyroid cancer.Sorafenib inhibits intracellular signaling pathways and induces cell cycle arrest and cell death in thyroid carcinoma cells irrespective of histological origin or BRAF mutational statusTransient partial response of poorly-differentiated thyroid carcinoma to sunitinib treatment: A case report.SCF(β-TRCP) suppresses angiogenesis and thyroid cancer cell migration by promoting ubiquitination and destruction of VEGF receptor 2.Patient Benefit-Risk Tradeoffs for Radioactive Iodine-Refractory Differentiated Thyroid Cancer TreatmentsThe Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions.Molecular genetics of papillary thyroid carcinoma: great expectations.Molecular genetics of thyroid cancer: implications for diagnosis, treatment and prognosis.Imaging for staging and management of thyroid cancerThyroid carcinoma: molecular pathways and therapeutic targetsTargeted radionuclide therapy.Role of B-Raf(V600E) in differentiated thyroid cancer and preclinical validation of compounds against B-Raf(V600E).Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.Contemporary management of papillary carcinoma of the thyroid gland.Phase I clinical trials in 56 patients with thyroid cancer: the M. D. Anderson Cancer Center experienceSurgical implications of B-RafV600E mutation in fine-needle aspiration of thyroid nodules.Pazopanib enhances paclitaxel-induced mitotic catastrophe in anaplastic thyroid cancerA 'silent' skull metastatic follicular thyroid carcinoma mimicking as a benign scalp tumor in a pregnant woman.Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways.Targeted molecular therapies in thyroid carcinoma.BRAF(V600E) and microenvironment in thyroid cancer: a functional link to drive cancer progression.MicroRNA expression profiles in the management of papillary thyroid cancer.Selective use of vandetanib in the treatment of thyroid cancer.
P2860
Q26748491-885EBB19-7509-4831-80A6-8CDCB9B5AE07Q26774734-A00F5028-E9FD-4F2C-BA46-48E0AEFBE37AQ27003934-06C35B4F-6B72-456B-86F6-12A08E0CB240Q28539208-4914199D-E72A-4AC5-9D75-869541D1AFBEQ33397349-CF6384D9-E94E-456A-B9BA-C7B02F74DEB3Q33760910-21249ACA-4DC1-4907-AE4E-84C29139AEB1Q33780551-904532B6-021B-48FD-A5D5-4A8C3BAE900FQ33934897-CA27E258-A498-48D8-AEC3-A0303A47DA49Q33982413-1B50AC35-3BFC-4FA4-845C-EC7B8D250D06Q34027466-6D4FE957-E30D-46C7-9B56-B84955C2AB7BQ34696283-A3F5B243-79B5-4B24-BBDD-1FEFA2F247F8Q34714310-550EC960-0450-43C8-809C-CD78ED2A8311Q34781888-97948F4D-DBA6-470A-8BBC-E695B55AAB14Q35023367-26610486-8D87-4522-AD02-4803675A946FQ35225620-E893794B-C389-42B6-8807-CE86D7819769Q35381593-B82F98D7-E059-414B-BFD1-0469949E0ABBQ35558293-DC5D9A7C-3960-487E-A60A-FF7363C9ED62Q35583906-69B53F1F-4E67-4C63-8501-C6C2C998EF37Q35603183-60157718-5E60-4A15-8189-AD4501318D5EQ35803876-D13E15FF-E82B-4E1D-AEB0-FDCA65416065Q36118305-FFC1D2B3-1DCF-49E6-8AF6-D49C4A2B9C45Q36366960-BED6FE6F-28C0-4686-BDA8-13BA239E8AF5Q36404008-7623510E-9F8E-4FBF-BCAD-5B78E5DCD391Q36949765-1E95490C-7F31-4BF2-A668-4F9D9A5061A4Q37035285-B014B427-73D7-487F-9487-6AC4F272D3F7Q37129052-E5A79483-66A0-4FC3-82A2-6E892FA92EFFQ37147768-A211CAAE-2E0F-4FB1-8756-E2F2ADABDF09Q37148148-8D27DBEB-56B3-4CC0-8297-6CDB1EF236F7Q37270522-80839E24-5364-4592-95A7-10788C70F587Q37402609-1506EB2C-1371-4E52-A18D-2EA968CDDCD1Q37411175-7834F0CF-2961-4C49-BCDE-AC0667160E4AQ37417441-96D3767A-8D04-43D6-B766-979B40900138Q37431090-89166CEB-4744-4934-ADBB-62C17F406248Q37526802-0400888B-B7DB-42E6-9F97-721F50F6FB3DQ37626120-49BDD71B-0DC2-4BA4-AB1E-22E9EFCE68E5Q37680195-FA0D0EF2-1853-45EF-BD03-BC1FB49E79F4Q37686162-32520E43-14AF-43D0-AB65-D8ED43A2FF1AQ37859169-6B470F01-233F-46B1-831E-11CD26E5E9CFQ38260896-452C93E7-3FDD-4057-883B-1A54442E08E2Q38546474-F48C4EE6-5EC4-4222-ABE2-07ED64D0A1A1
P2860
New therapeutic approaches for metastatic thyroid carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
New therapeutic approaches for metastatic thyroid carcinoma.
@ast
New therapeutic approaches for metastatic thyroid carcinoma.
@en
type
label
New therapeutic approaches for metastatic thyroid carcinoma.
@ast
New therapeutic approaches for metastatic thyroid carcinoma.
@en
prefLabel
New therapeutic approaches for metastatic thyroid carcinoma.
@ast
New therapeutic approaches for metastatic thyroid carcinoma.
@en
P1433
P1476
New therapeutic approaches for metastatic thyroid carcinoma.
@en
P2093
Eric Baudin
Martin Schlumberger
P304
P356
10.1016/S1470-2045(07)70034-7
P577
2007-02-01T00:00:00Z